# NIH Reporter #1R21AI199838-01

Development of a bispecific anti-gonococcal immunotherapeutic

**Recipient:** University of California, San Francisco

**Award Amount:** $457,126.00
**Ceiling:** $457,126.00

**Awarded:** August 19, 2026

**Identifier:** 1R21AI199838-01

The project will study antibodies against Neisseria gonorrhoeae and design and test bispecific antibodies intended to broaden strain coverage and support an immunotherapeutic approach to multidrug-resistant gonorrhea.

### Description

Project to develop bispecific antibodies targeting gonococcal lipooligosaccharide as a potential immunotherapy against multidrug-resistant gonorrhea.

[View original record](https://reporter.nih.gov/search/Z6-pLStXck6naeyMsC9RTw/project-details/11363079)
